APM Set Forth for Opioid-use Disorder Treatment
AMA and ASAM jointly developed and released a concept paper detailing a groundbreaking alternative
payment model (APM) for use by teams of addiction specialists, primary care
physicians and other health professionals to manage the full array of medical,
pharmaceutical and psychosocial care for opioid-use disorder (OUD) patients.
The Patient-Centered Opioid Addiction Treatment (P-COAT) model is expected
to increase the number of OUD patients who are able to lead satisfying,
productive lives through successful management of their condition while also
reducing spending on preventable costs associated with addiction, such as
emergency department visits and hospitalizations.
P-COAT aims to broaden access to proven, effective treatment for OUD by
supporting coordinated care by multiple health professionals and ending the
fragmentation and service gaps that have often characterized addiction
treatment. P-COAT includes a number of innovative features, including an add-on
payment for participating treatment teams that make use of clinically validated
digital care management tools to improve patient adherence to treatment
ASAM and the AMA are now seeking physician practices and insurers interested in
pilot testing the new payment model, who can submit their contact information here. The
organizations are also working with the House Energy and Commerce Committee on
potential inclusion of a provision establishing a Medicare demonstration
project of an alternative payment model for OUD in the legislation the
committee is developing to address the opioid epidemic. A discussion draft of
such a measure was included in legislation that cleared the Energy and Commerce Health
Subcommittee April 25.
more at AMA Wire.